Research

Energy balance

Targeting intestinal epithelial MyD88 therapeutically reduces fat mass and inflammation even after obesity is established, suggesting a potential treatment for existing obesity.

This study suggests that even after obesity develops, interventions that support intestinal health and reduce inflammation might help reverse fat gain. For now, this translates to focusing on dietary patterns that support gut barrier integrity and a diverse microbiome, rather than waiting for specific pharmaceutical targets.

GoodSupportsHIGH confidence
We found that the induction of IEC-MyD88 deletion after the onset of obesity rapidly and strongly reduced fat mass... we observed that fat mass remained significantly lower in IEC MyD88-KO mice and lasted until the end of the experimental period.
Amandine Everard et al. · Nature Communications · 2014

Why this rating

Strong animal model evidence for therapeutic efficacy, but lacks human translation.

Source

Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status

Amandine Everard et al. · Nature Communications · 2014

DOI 10.1038/ncomms6648

mechanism_onlyCited 230×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →